株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

肺動脈弁狭窄:世界の治験レビュー

Pulmonary Valve Stenosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 315197
出版日 ページ情報 英文 49 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
肺動脈弁狭窄:世界の治験レビュー Pulmonary Valve Stenosis Global Clinical Trials Review, H2, 2014
出版日: 2014年09月30日 ページ情報: 英文 49 Pages
概要

当レポートでは、肺動脈弁狭窄に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 肺動脈弁狭窄
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:心血管系疾患の治験件数に対する肺動脈弁狭窄の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:心血管系疾患の治験件数に対する肺動脈弁狭窄の治験件数比率

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望なスポンサー

有望な薬剤

最新の治験情報

治験のプロファイル

  • 代表的な企業の治験概要
    • CryoLife, Inc.
  • 代表的な大学・研究所における治験の概要
    • Boston Children's Hospital
    • Emory University
    • Guangdong Provincial People's Hospital
    • Competence Network for Congenital Heart Defects
    • National Center for Research Resources

5つの代表的な治験のプロファイル

付録

図表一覧

目次

GlobalData's clinical trial report, "Pulmonary Valve Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Pulmonary Valve Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Valve Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Valve Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Pulmonary Valve Stenosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Pulmonary Valve Stenosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pulmonary Valve Stenosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Pulmonary Valve Stenosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • CryoLife, Inc.
      • Clinical Trial Overview of CryoLife, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Boston Children's Hospital
      • Clinical Trial Overview of Boston Children's Hospital
      • Emory University
      • Clinical Trial Overview of Emory University
      • Guangdong Provincial People's Hospital
      • Clinical Trial Overview of Guangdong Provincial People's Hospital
      • Competence Network for Congenital Heart Defects
      • Clinical Trial Overview of Competence Network for Congenital Heart Defects
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Pulmonary Valve Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Pulmonary Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Pulmonary Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Pulmonary Valve Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Pulmonary Valve Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CryoLife, Inc., 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Provincial People's Hospital, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Competence Network for Congenital Heart Defects, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*

List of Figures

  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Proportion of Pulmonary Valve Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Pulmonary Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Pulmonary Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Pulmonary Valve Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Pulmonary Valve Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Pulmonary Valve Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Pulmonary Valve Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top